0      0

AM21-03: Challenges in Apheresis Cellular Collections during the COVID-19 Pandemic

Oct 17, 2021 11:15am ‐ Oct 17, 2021 12:15pm

Credits: None available.


The field of cellular therapy has become increasingly complicated in all aspects, including technical, patient, environment, and regulatory. For example, the logistics of apheresis collection as well as the utilization of fresh stem cell product have changed significantly during the current COVID-19 pandemic. In this session, different logistical solutions that apheresis collection facilities have used during the pandemic will be discussed. New regulatory requirements introduced during the COVID-19 pandemic will be reviewed (e.g new FDA guidance) and how these can be implemented into routine operations will be discussed.




Credits: None available.

You must be logged in and own this session in order to post comments.